Tuberculosis and Respiratory Diseases

Proposed Etiotypes for Chronic Obstructive Pulmonary Disease: Controversial Issues: Sang Hyuk Kim, Ji-Yong Moon, Kyung Hoon Min, Hyun Lee; Tuberc Respir Dis. 2024;87(3):221-233. Published online February 6, 2024; DOI: https://doi.org/10.4046/trd.2023.0194; Full text PubReader ePub PDF

Subphenotypes of Acute Respiratory Distress Syndrome: Advancing Towards Precision Medicine: Andrea R. Levine, Carolyn S. Calfee; Tuberc Respir Dis. 2024;87(1):1-11. Published online September 7, 2023; DOI: https://doi.org/10.4046/trd.2023.0104
Web of Science 2 Crossref 1; Full text PubReader ePub PDF

Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology: Won-Dong Kim; Tuberc Respir Dis. 2022;85(4):302-312. Published online July 13, 2022; DOI: https://doi.org/10.4046/trd.2022.0029
Web of Science 4 Crossref 6; Full text PubReader ePub PDF

Correlation between Telomere Length and Chronic Obstructive Pulmonary Disease–Related Phenotypes: Results from the Chronic Obstructive Pulmonary Disease in Dusty Areas (CODA) Cohort: Da Hye Moon, Jeeyoung Kim, Myoung Nam Lim, So Hyen Bak, Woo Jin Kim; Tuberc Respir Dis. 2021;84(3):188-199. Published online May 13, 2021; DOI: https://doi.org/10.4046/trd.2021.0015
Web of Science 4 Crossref 4; Full text PubReader ePub PDF Supplementary Material

New Era of Management Concept on Pulmonary Fibrosis with Revisiting Framework of Interstitial Lung Diseases: Arata Azuma, Luca Richeldi; Tuberc Respir Dis. 2020;83(3):195-200. Published online April 29, 2020; DOI: https://doi.org/10.4046/trd.2020.0005
Web of Science 2 Crossref 2; Full text PubReader ePub PDF

Clinical Phenotype of a First Unprovoked Acute Pulmonary Embolism Associated with Antiphospholipid Antibody Syndrome: Yong Sub Na, Seongsoo Jang, Seokchan Hong, Yeon Mok Oh, Sang Do Lee, Jae Seung Lee; Tuberc Respir Dis. 2019;82(1):53-61. Published online December 19, 2018; DOI: https://doi.org/10.4046/trd.2018.0045
Web of Science 2 Crossref 3; Full text PubReader PDF

Increased Risk of Exacerbation in Asthma Predominant Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome: Jisoo Park, Eun-Kyung Kim, Mi-Ae Kim, Tae-Hyung Kim, Jung Hyun Chang, Yon Ju Ryu, Sei Won Lee, Yeon-Mok Oh, Suk Joong Yong, Won-Il Choi, Kwang Ha Yoo, Ji-Hyun Lee; Tuberc Respir Dis. 2018;81(4):289-298. Published online March 7, 2018; DOI: https://doi.org/10.4046/trd.2017.0064
Web of Science 3 Crossref 2; Full text PubReader PDF

Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma: Mary Claire Rolfes, Young Jun Juhn, Chung-Il Wi, Youn Ho Sheen; Tuberc Respir Dis. 2017;80(2):113-135. Published online March 31, 2017; DOI: https://doi.org/10.4046/trd.2017.80.2.113
Web of Science 19 Crossref 20; Full text PubReader PDF

Study Design and Outcomes of Korean Obstructive Lung Disease (KOLD) Cohort Study: Tai Sun Park, Jae Seung Lee, Joon Beom Seo, Yoonki Hong, Jung-Wan Yoo, Byung Ju Kang, Sei Won Lee, Yeon-Mok Oh, Sang-Do Lee; Tuberc Respir Dis. 2014;76(4):169-174. Published online April 25, 2014; DOI: https://doi.org/10.4046/trd.2014.76.4.169
Web of Science 49 Crossref 37; Full text PubReader PDF

Respiratory Reviews in Asthma 2013: Tae-Hyung Kim; Tuberc Respir Dis. 2014;76(3):105-113. Published online March 29, 2014; DOI: https://doi.org/10.4046/trd.2014.76.3.105
Web of Science 1 Crossref 1; Full text PubReader PDF

Clinical Features according to the Frequency of Acute Exacerbation in COPD: Seung Jun Lee, Seung Hun Lee, Yu Eun Kim, Yu Ji Cho, Yi Yeong Jeong, Ho Cheol Kim, Jin Hyun Kim, Jin Jong You, Chul-Ho Yoon, Jong Deog Lee, Young Sil Hwang; Tuberc Respir Dis. 2012;72(4):367-373. Published online April 30, 2012; DOI: https://doi.org/10.4046/trd.2012.72.4.367
Crossref 7; Full text PubReader PDF

Clinical Year-in-Review of Chronic Obstructive Pulmonary Disease in Korea.: Kyeong Cheol Shin; Tuberc Respir Dis. 2011;71(1):1-7. Published online July 1, 2011; DOI: https://doi.org/10.4046/trd.2011.71.1.1; PDF

Comparison of Effectiveness and Adverse Reactions between Isoniazid 300 mg and 400 mg in Korean Patients with Pulmonary Tuberculosis.: I Nae Park, Sang Bum Hong, Yeon Mok Oh, Chae Man Lim, Sang Do Lee, Younsuck Koh, Woo Sung Kim, Dong Soon Kim, Won Dong Kim, Tae Sun Shim; Tuberc Respir Dis. 2006;60(1):44-48. Published online January 1, 2006; DOI: https://doi.org/10.4046/trd.2006.60.1.44
Crossref 5; PDF

35,770	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
6,233	Proposed Etiotypes for Chronic Obstructive Pulmonary Disease: Controversial Issues
6,613	Tuberculosis: Republic of Korea, 2021
12,563	Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
2,004	Effects of the Use of Beta-Blockers on Chronic Obstructive Pulmonary Disease Associated with Cardiovascular Comorbities: Systematic Review and Meta-analysis

Cited By 32	Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
Cited By 22	Tuberculosis: Republic of Korea, 2021
Cited By 15	Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
Cited By 12	Pulmonary Functions and Inflammatory Biomarkers in Post-Pulmonary Tuberculosis Sequelae
Cited By 12	Long-Term Outcome of Chronic Obstructive Pulmonary Disease: A Review

Search